Navigation Links
Global Lyme Alliance Partners With Ionica Sciences to Develop New Lyme Disease Diagnostic Test
Date:10/10/2017

Global Lyme Alliance (GLA), the leading 501(c)(3) dedicated to conquering Lyme disease through research, education and awareness, today announced that it has partnered with Ionica Sciences, an Ithaca, New York biotechnology company to accelerate the development of a highly sensitive Lyme disease diagnostic test.

The new test, called IonLyme™, targets Lyme disease bacterial proteins and is poised to transform the speed and accuracy of diagnosis over existing tests. The strategy is unique, distinguishing Ionica Sciences’ technology from all other Lyme tests on the market. The approach will allow earlier detection of infections than is currently possible. Moreover, it can also be rapidly adapted to detect other tick-borne diseases in the near future. GLA and Ionica expect IonLyme to be extremely sensitive, and highly specific and therefore very accurate.

GLA has seeded Ionica Sciences with approximately $175,000 in funding to support the development and launch of the test, which confirms the presence or absence of disease at or very near to the onset of symptoms. GLA’s support, in partnership with Cornell University’s Kevin M. McGovern Family Center for Venture Development in the Life Sciences, where Ionica Sciences is incubated, has been crucial to the development of IonLyme.

“GLA takes a creative, innovative, and scientifically sound approach to our research program, and this is especially important when trying to find a reliable technology for Lyme diagnostics,” said GLA Chairman Robert Kobre. “We believe that by investing alongside Cornell’s venture arm, we can help Ionica move from early development to a commercially available, effective test. GLA makes targeted, early stage investments and we have great confidence in Joel, Omar and all of the Ionica team.”

Said Omar Green, Ph.D., Ionica’s CEO: “Without the support of GLA, IonLyme would have remained a good idea on a whiteboard. Now, with the generous support of GLA, Ionica Sciences is rapidly developing a promising new technology that will transform Lyme disease testing as it is currently practiced.”

Early diagnosis is crucial in treating Lyme, the most common vector-borne disease in the U.S. with 329,000 new cases annually. However, more than 50 percent of patients are initially misdiagnosed because current tests are highly inaccurate. Most detect antibodies in the blood that show exposure to Lyme disease instead of targeting Borrelia burgdorferi, the bacterium which causes the disease. Misdiagnosed individuals often go untreated and the lingering infection can cause persistent debilitating symptoms, including severe arthritis, memory and cognitive loss, and cardiac failure.

Today’s commonly used two-tiered diagnostic test for Lyme disease measures the patient’s antibody response to a Lyme infection. As a result, some patients may receive false negative test results because there hasn’t been enough time for antibodies to develop, or because their immune system may be suppressed. However, Ionica’s test detects the presence of key Borrelia proteins in blood via a highly sensitive spectrographic signature. It can detect early Lyme, track the progress of the disease and the effectiveness of treatment.

“GLA is thinking in the best interests of patients who have been waiting a long time for a test that offers a more precise diagnosis than current tests.” said Scott Santarella, GLA’s CEO. “By investing in industry we want to come up with the tools to help expedite a solution to this problem which will impact the lives of millions.”

Ionica hopes to bring the new IonLyme test to the Food and Drug Administration for approval later in 2018.
______________________________________________________________________________________________________________________
ABOUT GLOBAL LYME ALLIANCE
Global Lyme Alliance is the leading 501 © (3) dedicated to conquering Lyme and other tick-borne diseases through research, education and awareness. GLA has gained national prominence for funding the most urgent and promising research in the field, while expanding education and awareness programs for the general public and physicians. Learn more at GLA.org.

Read the full story at http://www.prweb.com/releases/2017/10/prweb14777644.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. iFred launches Global Hope Challenge on World Mental Health Day to inspire #OneThing for #Hope
2. K&A Global Inc. Reveal How to Transform from Ordinary to Extraordinary
3. Gavin Walsh of MarketStorm Global on How to Transform a Company Culture from Good to GREAT
4. Omega Family Global Co-Locates its Surrogacy, Insurance, Legal, and Real Estate Entities
5. Pros and Cons of New Minimal In Vitro Fertilization Technique (IVF) Point Out the Crucial Role of a Surrogacy Agency, says Global Fertility Concepts
6. Introducing #CHECKYOURSELFIE; Keep A Breast Foundation Launches Selfless Selfies, A New Global Campaign for Young People
7. World Premiere of "Call On Me" Music Video Spotlights Global Message of Hope
8. Top Lyme Disease Researcher Joins Global Lyme Alliance as New Chief Scientific Officer
9. Clear Global Enters into Agreement with First Ever Post Graduate Program in Aesthetic Orthodontics
10. BC Children’s Hospital Orthopaedic team creating first-ever global hip dysplasia registry and standardized assessment tool to benefit children worldwide
11. The Future of Work - Global Leaders Meet in Malaga, Spain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
Breaking Medicine Technology: